F
Fennec Pharmaceuticals D
D
FENC
8.07000
USD
0.22
(2.80%)
مغلق
حجم التداول
192
الربح لكل سهم
-0
العائد الربحي
-
P/E
-15
حجم السوق
222,883,256
الأخبار المقالات
العنوان: Fennec Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.